These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 15324812

  • 21. Resistance to fas-induced apoptosis in cells from human atherosclerotic lesions: elevated Bcl-XL inhibits apoptosis and caspase activation.
    Yang Z, Gagarin D, Ramezani A, Hawley RG, McCaffrey TA.
    J Vasc Res; 2007; 44(6):483-94. PubMed ID: 17657164
    [Abstract] [Full Text] [Related]

  • 22. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
    Hougardy BM, van der Zee AG, van den Heuvel FA, Timmer T, de Vries EG, de Jong S.
    Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
    [Abstract] [Full Text] [Related]

  • 23. Bid and calpains cooperate to trigger oxaliplatin-induced apoptosis of cervical carcinoma HeLa cells.
    Anguissola S, Köhler B, O'Byrne R, Düssmann H, Cannon MD, Murray FE, Concannon CG, Rehm M, Kögel D, Prehn JH.
    Mol Pharmacol; 2009 Nov; 76(5):998-1010. PubMed ID: 19713356
    [Abstract] [Full Text] [Related]

  • 24. Mitochondria from TRAIL-resistant prostate cancer cells are capable of responding to apoptotic stimuli.
    Liang Y, Eid MA, Lewis RW, Kumar MV.
    Cell Signal; 2005 Feb; 17(2):243-51. PubMed ID: 15494215
    [Abstract] [Full Text] [Related]

  • 25. Bid is required in NPe6-PDT-induced apoptosis.
    Wan Q, Liu L, Xing D, Chen Q.
    Photochem Photobiol; 2008 Feb; 84(1):250-7. PubMed ID: 18173728
    [Abstract] [Full Text] [Related]

  • 26. Structural model of the BCL-w-BID peptide complex and its interactions with phospholipid micelles.
    Denisov AY, Chen G, Sprules T, Moldoveanu T, Beauparlant P, Gehring K.
    Biochemistry; 2006 Feb 21; 45(7):2250-6. PubMed ID: 16475813
    [Abstract] [Full Text] [Related]

  • 27. Mitochondrial targeting of tBid/Bax: a role for the TOM complex?
    Ott M, Norberg E, Zhivotovsky B, Orrenius S.
    Cell Death Differ; 2009 Aug 21; 16(8):1075-82. PubMed ID: 19521421
    [Abstract] [Full Text] [Related]

  • 28. Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells.
    Hussain AR, Al-Jomah NA, Siraj AK, Manogaran P, Al-Hussein K, Abubaker J, Platanias LC, Al-Kuraya KS, Uddin S.
    Cancer Res; 2007 Apr 15; 67(8):3888-97. PubMed ID: 17440103
    [Abstract] [Full Text] [Related]

  • 29. Gamma irradiation of human leukaemic cells HL-60 and MOLT-4 induces decrease in Mcl-1 and Bid, release of cytochrome c, and activation of caspase-8 and caspase-9.
    Tichý A, Záskodová D, Pejchal J, Rezácová M, Osterreicher J, Vávrová J, Cerman J.
    Int J Radiat Biol; 2008 Jun 15; 84(6):523-30. PubMed ID: 18470751
    [Abstract] [Full Text] [Related]

  • 30. Glucosamine sulfate-induced apoptosis in chronic myelogenous leukemia K562 cells is associated with translocation of cathepsin D and downregulation of Bcl-xL.
    Wang Z, Liang R, Huang GS, Piao Y, Zhang YQ, Wang AQ, Dong BX, Feng JL, Yang GR, Guo Y.
    Apoptosis; 2006 Oct 15; 11(10):1851-60. PubMed ID: 16850161
    [Abstract] [Full Text] [Related]

  • 31. Impaired kinetics of Bax-GFP and Smac/DIABLO-GFP in caspase-8- and bid-silenced and Bcl-2 overexpressed breast cancer MCF-7 cells exposed to camptothecin.
    Górka M, Lamparska-Przybysz M, Motyl T.
    Cell Mol Biol (Noisy-le-grand); 2007 Jan 21; 52 Suppl():OL915-22. PubMed ID: 17666167
    [Abstract] [Full Text] [Related]

  • 32. A novel Bcl-2 small molecule inhibitor 4-(3-methoxy-phenylsulfannyl)-7-nitro-benzofurazan-3-oxide (MNB)-induced apoptosis in leukemia cells.
    Zhang M, Ling Y, Yang CY, Liu H, Wang R, Wu X, Ding K, Zhu F, Griffith BN, Mohammad RM, Wang S, Yang D.
    Ann Hematol; 2007 Jul 21; 86(7):471-81. PubMed ID: 17396262
    [Abstract] [Full Text] [Related]

  • 33. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.
    Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347
    [Abstract] [Full Text] [Related]

  • 34. A new assay for the discovery of Bcl-XL inhibitors.
    Pisoni C, Cimoli G, Resconi A, Losi D, Lorenzetti R, Parodi S, Carrano L.
    Farmaco; 2005 Dec 07; 60(11-12):938-43. PubMed ID: 16054143
    [Abstract] [Full Text] [Related]

  • 35. Cathepsin B is involved in the apoptosis intrinsic pathway induced by Bacillus Calmette-Guérin in transitional cancer cell lines.
    Sandes E, Lodillinsky C, Cwirenbaum R, Argüelles C, Casabé A, Eiján AM.
    Int J Mol Med; 2007 Dec 07; 20(6):823-8. PubMed ID: 17982689
    [Abstract] [Full Text] [Related]

  • 36. Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists.
    McDonnell JM, Fushman D, Milliman CL, Korsmeyer SJ, Cowburn D.
    Cell; 1999 Mar 05; 96(5):625-34. PubMed ID: 10089878
    [Abstract] [Full Text] [Related]

  • 37. Drug targeting via retrometabolic approaches.
    Bodor N, Buchwald P.
    Pharmacol Ther; 1997 Mar 05; 76(1-3):1-27. PubMed ID: 9535166
    [Abstract] [Full Text] [Related]

  • 38. Therapeutic applications of apoptosis research.
    Bamford M, Walkinshaw G, Brown R.
    Exp Cell Res; 2000 Apr 10; 256(1):1-11. PubMed ID: 10739645
    [No Abstract] [Full Text] [Related]

  • 39. Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes.
    Zveik O, Rechtman A, Haham N, Adini I, Canello T, Lavon I, Brill L, Vaknin-Dembinsky A.
    Int J Mol Sci; 2022 Jun 27; 23(13):. PubMed ID: 35806122
    [Abstract] [Full Text] [Related]

  • 40. Programmed cell death in aortic aneurysm and dissection: A potential therapeutic target.
    Chakraborty A, Li Y, Zhang C, Li Y, LeMaire SA, Shen YH.
    J Mol Cell Cardiol; 2022 Feb 27; 163():67-80. PubMed ID: 34597613
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.